Sonoma Pharmaceuticals posts updated investor presentation with no material new information

Sonoma Pharmaceuticals, Inc.

Filed updated investor presentation as of April 7, 2025, under Item 8.01.
Presentation contains only standard disclaimers and forward-looking statements; no new financial or operational data disclosed.
No changes to guidance, product pipeline, revenue, or other key metrics were reported.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.